BioTech Pharma Process Engineer

agap2 is a European engineering and operational consulting group founded in 2005 and specialized in the industry. We work in the Pharma Biotechnology Medical Devices Energy Infrastructure Transportation Chemicals and Information Technology sectors.

As a consultant you will have to support our clients in the realization of their projects on site by bringing your expertise and your skills.

You are agile and eager to adapt to different work environments that will fuel your curiosity of seeing whats behind closed doors of the biggest projects of our clients portfolio.

Tasks

• Feasibility studies Concept Design Basic Design and Detailed Design for process equipment (USP/DSP)
• Creation and review of URS PFDs and P&ID
• Plan and support to FAT SAT P&ID walkdowns C&Q activities
• Management of external companies supervision of deliverables and schedule
• Meeting organization and communication with internal stakeholders such as QA MSAT Engineering
• Creation of tender documentation for procurement

Requirements

• Engineering diploma in biotechnology bioprocess chemical engineering or similar
• Experience in facility engineering and/or experience in manufacturing/C&Q
• Good knowledge in GMP
• Readiness to work in international environment
• English and German spoken and written
• Excellent written and verbal communication skills

Benefits

• Joining a group with strong development potential that aims to improve your employability on challenging and varied projects
• Joining a structure that has been established in Switzerland for a long time with a client portfolio that includes the leaders in the sector
• Having a sustainable job with stability and access to a real collaboration
• Benefit from training with accredited and certified centers
• Having a local management to support you in the achievement of your missions and in the development of your career
• Being part of a dynamic committed team with real human values that we live by every day

Only applications from Swiss and EU citizens will be considered.